dc.creatorSantos, Erika Maria Monteiro
dc.creatorValentin, Mev Dominguez
dc.creatorCarneiro, Felipe
dc.creatorOliveira, Ligia Petrolini de
dc.creatorFerreira, Fabio de Oliveira
dc.creatorAguiar Junior, Samuel
dc.creatorNakagawa, Wilson Toshihiko
dc.creatorGomy, Israel
dc.creatorFerraz, Victor Evangelista de Faria
dc.creatorSilva Junior, Wilson Araújo da
dc.creatorCarraro, Dirce Maria
dc.creatorRossi, Benedito Mauro
dc.date.accessioned2013-10-21T11:11:42Z
dc.date.accessioned2018-07-04T15:59:19Z
dc.date.available2013-10-21T11:11:42Z
dc.date.available2018-07-04T15:59:19Z
dc.date.created2013-10-21T11:11:42Z
dc.date.issued2012
dc.identifierBMC CANCER, LONDON, v. 12, FEB 9, 2012
dc.identifier1471-2407
dc.identifierhttp://www.producao.usp.br/handle/BDPI/35267
dc.identifier10.1186/1471-2407-12-64
dc.identifierhttp://dx.doi.org/10.1186/1471-2407-12-64
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1630116
dc.description.abstractBackground: Lynch syndrome (LS) is the most common form of inherited predisposition to colorectal cancer (CRC), accounting for 2-5% of all CRC. LS is an autosomal dominant disease characterized by mutations in the mismatch repair genes mutL homolog 1 (MLH1), mutS homolog 2 (MSH2), postmeiotic segregation increased 1 (PMS1), post-meiotic segregation increased 2 (PMS2) and mutS homolog 6 (MSH6). Mutation risk prediction models can be incorporated into clinical practice, facilitating the decision-making process and identifying individuals for molecular investigation. This is extremely important in countries with limited economic resources. This study aims to evaluate sensitivity and specificity of five predictive models for germline mutations in repair genes in a sample of individuals with suspected Lynch syndrome. Methods: Blood samples from 88 patients were analyzed through sequencing MLH1, MSH2 and MSH6 genes. The probability of detecting a mutation was calculated using the PREMM, Barnetson, MMRpro, Wijnen and Myriad models. To evaluate the sensitivity and specificity of the models, receiver operating characteristic curves were constructed. Results: Of the 88 patients included in this analysis, 31 mutations were identified: 16 were found in the MSH2 gene, 15 in the MLH1 gene and no pathogenic mutations were identified in the MSH6 gene. It was observed that the AUC for the PREMM (0.846), Barnetson (0.850), MMRpro (0.821) and Wijnen (0.807) models did not present significant statistical difference. The Myriad model presented lower AUC (0.704) than the four other models evaluated. Considering thresholds of >= 5%, the models sensitivity varied between 1 (Myriad) and 0.87 (Wijnen) and specificity ranged from 0 (Myriad) to 0.38 (Barnetson). Conclusions: The Barnetson, PREMM, MMRpro and Wijnen models present similar AUC. The AUC of the Myriad model is statistically inferior to the four other models.
dc.languageeng
dc.publisherBIOMED CENTRAL LTD
dc.publisherLONDON
dc.relationBMC CANCER
dc.rightsCopyright BIOMED CENTRAL LTD
dc.rightsopenAccess
dc.titlePredictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución